Abeona Therapeutics Inc. (ABEO)
NASDAQ·Healthcare·Biotechnology
$5.39
+0.84%
Mkt Cap $304.64M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 17, 2026 | $4.42M | $5.40M | +22.05% | -$0.35 | -$0.34 | +2.86% | — | — |
| Q4 2025 Nov 12, 2025 | $5.65M | — | — | -$0.27 | -$0.10 | +62.96% | — | — |
| Q3 2025 Aug 14, 2025 | $6.52M | $400.00K | -93.87% | -$0.39 | $1.71 | +538.46% | — | — |
| Q2 2025 May 15, 2025 | — | — | — | -$0.35 | -$0.24 | +31.43% | — | — |
| Q1 2025 Mar 20, 2025 | $83.33K | — | — | -$0.43 | -$0.24 | +44.19% | — | — |
| Q4 2024 Nov 14, 2024 | $83.33K | — | — | -$0.38 | -$0.31 | +18.42% | — | — |
| Q3 2024 Aug 12, 2024 | $80.00K | — | — | -$0.33 | -$0.75 | -127.27% | — | — |
| Q2 2024 May 15, 2024 | $170.00K | — | — | -$0.47 | -$0.53 | -12.77% | — | — |
| Q1 2024 Mar 18, 2024 | — | $2.82M | — | -$0.51 | -$0.64 | -25.49% | — | — |
| Q4 2023 Nov 13, 2023 | — | — | — | -$0.53 | -$0.48 | +9.43% | — | — |
| Q3 2023 Aug 8, 2023 | — | $3.50M | — | -$0.66 | -$0.44 | +33.33% | — | — |
| Q2 2023 May 11, 2023 | — | — | — | -$0.58 | -$0.54 | +6.90% | — | — |
| Q1 2023 Mar 29, 2023 | $1.00M | $68.00K | -93.20% | -$0.75 | $1.53 | +304.00% | — | — |
| Q4 2022 Nov 14, 2022 | — | — | — | -$1.78 | -$1.48 | +16.85% | — | — |
| Q3 2022 Aug 11, 2022 | — | $1.00M | — | -$1.25 | -$2.08 | -66.40% | — | — |
| Q2 2022 May 13, 2022 | $253.73K | $346.00K | +36.36% | -$2.00 | -$2.50 | -25.00% | — | — |
| Q1 2022 Mar 31, 2022 | — | $3.00M | — | -$3.25 | -$3.50 | -7.69% | — | — |
| Q4 2021 Nov 15, 2021 | — | — | — | -$4.00 | -$4.00 | +0.00% | — | — |
| Q3 2021 Jul 28, 2021 | — | — | — | -$4.00 | -$4.00 | +0.00% | — | — |
| Q2 2021 May 18, 2021 | — | — | — | -$4.75 | -$4.25 | +10.53% | — | — |